Documents Médias TradaCasino.com Announces Fantastic New Player Bonuses. Up to £/€1500 Available in Free Money Bonuses
Documents Médias Multimodal Treatment of Peritoneal Metastases Offers Hope for Many Patients With Colorectal Cancer
Documents Médias Itau Unibanco Holding S.A. - Announcement to the Market - Trading of Own Shares for Treasury
Documents Médias River Advice and International Shipping Partners Establish the World's Leading Passenger Ship Management Company
Documents Médias Langham Hospitality Group Offers "Double the Extra Mile" Group Meeting Offer for Second Consecutive Year
Documents Médias Social Benefits and Empowerment Through Sport Will be Subject of Headline Debate at Doha GOALS
Documents Médias Athena Smartcard Completes the Supply of 15 Million eHealth Smart Card Modules in Italy and is Expected to Supply 7 Million Additional Units in 2013
Documents Médias Discounted Firetrap Range Lands on SportsDirect.com Ready for the Festive Party Season!
Documents Médias Keryx Biopharmaceuticals Initiates Phase 2 Study of Zerenex™ (ferric citrate) for the Treatment of Patients with Non-Dialysis Dependent Chronic Kidney Disease
Documents Médias Frost & Sullivan: Miniaturization of Medical Devices Reduces Mortality Rates among Cardiac Dysrhythmia Patients
Documents Médias Frost & Sullivan: U.S. Medical Imaging Informatics Industry Reconnects with Growth in the Enterprise Image Archiving Market
Documents Médias Medivir Announces Plans for a Phase II All-oral Study of Simeprevir (TMC435) and VX-135 for the Treatment of Hepatitis C to be Conducted by Janssen and Vertex
Documents Médias Janssen Announces Collaboration With Vertex On Phase 2 Study To Investigate An All-Oral Regimen Of Simeprevir (TMC435) And VX-135 For Treatment Of Hepatitis C